Point72 »

Prelude Therapeutics shares owned by Point72

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Point72

Quarter filed Position value Share count Share price at filing
2024-09-30 $11k 5.2k 2.07

More positions owned by Point72

Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Broadcom Call Option (AVGO)
Cisco Systems Call Option (CSCO)
Nike CL B Call Option (NKE)
Deere & Company Call Option (DE)
Adobe Systems Incorporated (ADBE)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Bristol Myers Squibb Call Option (BMY)
Accenture Plc Ireland Shs Class A Call Option (ACN)
NVIDIA Corporation Call Option (NVDA)
McKesson Corporation (MCK)
Bruker Corporation (BRKR)
General Motors Company (GM)

View all positions for Point72

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
Deerfield Management Company
Boxer Capital
T. Rowe Price Associates
BlackRock
BlackRock
Vanguard Group
ExodusPoint Capital Management
Avidity Partners Management
Massachusetts Financial Services
Geode Capital Management
Marshall Wace
Sio Capital Management
Morgan Stanley

View all funds holding Prelude Therapeutics